Skye Bioscience, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2016 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Skye Bioscience, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2016 to 2023.
  • Skye Bioscience, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 38.8M shares, a 393% increase year-over-year.
  • Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 7.01M shares, a 215% increase from 2022.
  • Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 2.22M shares, a 99.5% decline from 2021.
  • Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 407M shares, a 75.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 7.01M +4.78M +215% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 2.22M -404M -99.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 407M +175M +75.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 231M +61.9M +36.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 170M +48.4M +40% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 121M +93.2M +334% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 27.9M +8.96M +47.3% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-19
2016 18.9M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.